SureTrader SPDR Advertisement
Home > Boards > US OTC > Biotechs > PharmaCyte Biotech Inc. (PMCB)

NVLX

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
NYC Trader Member Profile
Member Level 
Followed By 1,178
Posts 141,901
Boards Moderated 8
Alias Born 01/25/09
160x600 placeholder
Advertisement
PharmaCyte Biotech Executives Interviewed on Role of Leaders in Oncology for Development of Its Clinical Trials "GlobeNewswire Inc." - 9/2/2015 9:00:00 AM
PharmaCyte Biotech Announces Successful Completion of Interim Audit of GMP Facility for the Production of Cell-in-a-Box for C... "GlobeNewswire Inc." - 8/25/2015 9:38:50 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 8/25/2015 6:06:25 AM
PharmaCyte Biotech’s Scientific Advisory Board Members Co-Author Major Review on Pancreatic Cancer "GlobeNewswire Inc." - 8/19/2015 9:00:00 AM
PharmaCyte Biotech Updates Progress of cGMP Facility for the Production of Cell-in-a-Box for Clinical Trials "GlobeNewswire Inc." - 8/6/2015 9:30:00 AM
Chardan Releases Industry Report Covering PharmaCyte Biotech "GlobeNewswire Inc." - 8/4/2015 9:00:00 AM
Annual Report (10-k) "Edgar (US Regulatory)" - 7/29/2015 4:05:04 PM
PharmaCyte Biotech Begins Second Follow-Up Study on Ascites "GlobeNewswire Inc." - 7/23/2015 9:20:00 AM
PharmaCyte Biotech Appoints Renowned Oncologist Dr. Manuel Hidalgo to Scientific Advisory Board "GlobeNewswire Inc." - 7/16/2015 9:10:00 AM
Notification That Annual Report Will Be Submitted Late (nt 10-k) "Edgar (US Regulatory)" - 7/14/2015 4:16:53 PM
PharmaCyte Biotech Drug Delivery Platform Limited only by Imagination "InvestorsHub NewsWire" - 7/9/2015 10:00:00 AM
PharmaCyte Biotech Appoints American Stock Transfer as New Stock Transfer Agent "GlobeNewswire Inc." - 7/9/2015 9:20:00 AM
PharmaCyte Biotech Releases HealthWatch Segment Featured on Discovery Channel "GlobeNewswire Inc." - 6/30/2015 8:30:00 AM
PharmaCyte Biotech’s Cancer and Diabetes Treatments Airing Nationwide on Discovery Channel "GlobeNewswire Inc." - 6/29/2015 8:30:00 AM
PharmaCyte Biotech Enters Into Research and Consulting Agreements With University of Technology Sydney "GlobeNewswire Inc." - 6/23/2015 9:25:00 AM
PharmaCyte Biotech Showcasing Technology and Treatments at 2015 BIO International Convention "GlobeNewswire Inc." - 6/16/2015 9:25:00 AM
PharmaCyte Biotech Advances Cannabinoid Research With Schedule 1 License "GlobeNewswire Inc." - 6/15/2015 9:25:00 AM
PharmaCyte Biotech’s Diabetes Treatment to Be Presented at Austrodrugs 2015 "GlobeNewswire Inc." - 6/12/2015 9:25:00 AM
PharmaCyte Biotech Officers to Attend 2015 BIO International Convention "GlobeNewswire Inc." - 6/10/2015 9:25:00 AM
PharmaCyte Biotech’s Contract Research Organization Voted Australia’s Favorite CRO for 2015 "GlobeNewswire Inc." - 6/9/2015 9:25:00 AM
PharmaCyte Biotech Releases Corporate Video "GlobeNewswire Inc." - 6/1/2015 7:48:02 AM
PharmaCyte Biotech to Conduct Additional Study on Malignant Ascites "GlobeNewswire Inc." - 5/29/2015 9:25:00 AM
PharmaCyte Biotech to Attend Annual Meeting of the American Society of Clinical Oncology "GlobeNewswire Inc." - 5/26/2015 9:30:00 AM
PharmaCyte Biotech's Melligen Cells Prove Safe in First Preclinical Test "GlobeNewswire Inc." - 5/6/2015 9:30:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/29/2015 9:01:24 AM
NYC Trader Member Level  Friday, 05/10/13 07:49:08 AM
Re: None
Post # of 40089 
NVLX
Link: http://www.otcmarkets.com/stock/NVLX/company-info
Ticker: $NVLX
OTC Market Tier: OTCQB
CIK code: 0001157075
Company name: Nuvilex, Inc.
Company website: http://www.nuvilex.com
Incorporated In: NV, USA


Visit my board"NY Penny Stock Exchange" for today's pick at http://investorshub.advfn.com/boards/board.aspx?board_id=16752
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist